Table III.
Parameters | Risk ratio | 95% confidence interval | P-value |
---|---|---|---|
Primary tumor | |||
T1 | 1 | ||
T2-4 | 0.371 | 0.0528–2.618 | 0.3204 |
Lymph node metastasis | |||
N0 | 1 | ||
N-positive | 27.778 | 2.632–333.33 | 0.0056 |
Lymphatic invasion | |||
Negative | 1 | ||
Positive | 0.924 | 0.104–8.197 | 0.9435 |
Vein invasion | |||
Negative | 1 | ||
Positive | 8.403 | 0.827–83.333 | 0.0719 |
Differentiation status | |||
Differentiated | 1 | ||
Undifferentiated | 2.933 | 0.946–9.091 | 0.0623 |
Immunostaining for NICD | |||
Positive | 1 | ||
Negative | 2.0747 | 0.451–9.524 | 0.3486 |
NICD, NOTCH1 intracellular cytoplasmic domain.